MedTrace Logo

Therapy With Verapamil or Carvedilol in Chronic Heart Failure

NCT00374465 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2006-09-11

No results posted yet for this study

Summary

The aim of this study is to compare the effect of treatment with verapamil or carvedilol on long-term outcomes in stable, chronic heart failure secondary to non-ischemic cardiomyopathy.

Conditions

  • Dilated Cardiomyopathy

Interventions

DRUG

Verapamil

DRUG

Carvedilol

Sponsors & Collaborators

  • Medical University of Silesia

    lead OTHER

Principal Investigators

  • Jan Wodniecki, Prof. · Medical University of Silesia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Completion
2008-05-31

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00374465 on ClinicalTrials.gov